Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Invivo Therapeutics Holdings Corporation (NVIV)  
$0.40 0.01 (2.44%) as of 4:30 Fri 6/14


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 21,170,000
Market Cap: 8.46(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2102 - $1.39
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   InVivo Therapeutics Holdings is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. Co.'s Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The Neuro-Spinal Scaffold implant is intended to provide support to the surrounding tissue after injury, minimize expansion of areas of necrosis, and provide a biomaterial substrate for the body's own healing/repair processes following injury. The Neuro-Spinal Scaffold is composed of poly lactic-co-glycolic acid and Poly-L-Lysine biocompatible and bioresorbable polymers.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 330,000
Total Sell Value $0 $0 $0 $123,030
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 2
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 458
  Page 18 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Reynolds Francis CEO, CFO   •       •       •   2012-12-17 4 AS $1.60 $6,830 D/D (4,250) 14,343,660     -
   Reynolds Francis CEO, CFO   •       •       •   2012-12-14 4 AS $1.60 $7,073 D/D (4,250) 14,347,910     -
   Reynolds Francis CEO, CFO   •       •       •   2012-12-13 4 AS $1.60 $6,800 D/D (4,250) 14,352,160     -
   Reynolds Francis CEO, CFO   •       •       •   2012-12-12 4 AS $1.61 $7,012 D/D (4,250) 14,356,410     -
   Reynolds Francis CEO, CFO   •       •       •   2012-12-11 4 AS $1.67 $7,146 D/D (4,250) 14,360,660     -
   Reynolds Francis CEO, CFO   •       •       •   2012-12-10 4 AS $1.66 $7,058 D/D (4,250) 14,364,910     -
   Reynolds Francis CEO, CFO   •       •       •   2012-12-07 4 AS $1.67 $7,163 D/D (4,250) 14,369,160     -
   Reynolds Francis CEO, CFO   •       •       •   2012-12-06 4 AS $1.65 $7,018 D/D (4,250) 14,373,410     -
   Hess Brian CHIEF SCIENCE OFFICEROfficer   •       –      –    2012-09-21 3 IO $0.00 $0 D/D 0 2,100     -
   Langer Robert 10% Owner   –       –       •   2012-07-02 4 S $2.39 $48,265 D/D (20,220) 7,697,113     -
   Langer Robert 10% Owner   –       –       •   2012-06-29 4 S $2.31 $57,167 D/D (24,780) 7,717,333     -
   Langer Robert 10% Owner   –       –       •   2012-06-28 4 S $2.30 $34,560 D/D (15,000) 7,742,113     -
   Langer Robert 10% Owner   –       –       •   2012-06-27 4 S $2.40 $32,280 D/D (13,450) 7,757,113     -
   Langer Robert 10% Owner   –       –       •   2012-06-26 4 S $2.42 $306,251 D/D (126,550) 7,770,563     -
   Langer Robert 10% Owner   –       –       •   2012-04-16 4 S $2.40 $383,616 D/D (159,840) 7,897,113     -
   Langer Robert 10% Owner   –       –       •   2012-04-13 4 S $2.39 $95,982 D/D (40,160) 8,056,953     -
   Reynolds Francis CEO, CFO   •       •       •   2012-01-06 4 S $2.53 $244,375 D/D (96,503) 14,647,660     -
   Reynolds Francis CEO, CFO   •       •       •   2012-01-05 4 S $2.63 $286,779 D/D (109,000) 14,744,163     -
   Reynolds Francis CEO, CFO   •       •       •   2012-01-04 4 S $2.62 $116,791 D/D (44,497) 14,853,163     -
   Reynolds Francis CEO, CFO   •       •       •   2011-12-28 4 S $2.74 $392,645 D/D (143,500) 15,004,160     -
   Reynolds Francis CEO, CFO   •       •       •   2011-11-29 4 S $2.52 $239,020 D/D (95,000) 14,909,160     -
   Reynolds Francis Chief Executive OfficerOfficer   •       •       •   2010-10-26 3 IO $0.00 $0 D/D 0 15,147,660     -
   Langer Robert 10% Owner   –       –       •   2010-10-26 3 IO $0.00 $0 D/D 0 8,262,360     -
   Nolen George Director   –       •      –    2010-10-26 3 IO $0.00 $0 D/D 0 10,000     -
   Pedra Christi Director   –       •      –    2010-10-26 3 IO $0.00 $0 D/D 0 10,000     -

  458 Records found
  Previous  10  11  12  13  14  15  16  17  18  19   
  Page 18 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed